Insider filing · ETON
David Krempa
Chief Business Officer
profile →
Eton Pharmaceuticals, Inc.
ETON · Healthcare · 14 filings in 24 months
ticker →
David Krempa sold $3.2M of Eton Pharmaceuticals (ETON)
Executed May 22, disclosed May 27, 5 days later.
Value, as filed
$3.2M
99,481 sh across 4 lots
Executed
May 22
the trade date, as filed
Disclosed
May 27
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DKDavid Krempa (Chief Business Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Eton Pharmaceuticals, Inc. (ETON). The largest single filing was $3.2M of ETON (99,481 sh across 4 lots, as filed), executed May 22.
The name
ETONHealthcare · Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by David Krempa in ETON
ETONSALE
Eton Pharmaceuticals, Inc.
$229K4,166 sh × $55.07
Exec Oct 6
Filed Oct 6 · 4:49 PM ET ETONSALE Eton Pharmaceuticals, Inc. $1.6M
25,000 sh × $65.07
Exec Aug 24
Filed Aug 24 · 5:19 PM ET ETONSALE Eton Pharmaceuticals, Inc. $504K
34,000 sh across 3 lots
Exec Jun 12 2025
Filed Jun 16 2025 · 5:30 PM ET